❓ WA Parliamentary Question on Notice regarding referrals and treatment statistics for the Perth Children's Hospital Gender Diversity Service in 2024, including puberty blockers and cross-sex hormones.
AnsweredQoN 301Legislative Council
QuestionView source ↗
I refer to the Perth Children’s Hospital Gender Diversity Service, and I ask: (a) how many referrals did the Perth Children’s Hospital Gender Diversity Service receive in the 2024 calendar year; (b) how many children and adolescents received treatment in the 2024 calendar year; (c) how many children and adolescents commenced stage one puberty blocker treatment in the 2024 calendar year; (d) how many children are currently receiving stage one puberty blocker treatment; (e) how many children commenced stage two cross-sex hormone treatment in the 2024 calendar year; (f) how many children and adolescents are currently receiving stage two cross-sex hormone treatment; (g) what was the age of the youngest child to receive treatment in 2024; and (h) what is the age of the youngest child who has received treatment?
AnswerView source ↗
Answered
12 August 2025
Responded by
Parliamentary Secretary to the Minister for Health
Response time
6 days
(a) The Child and Adolescent Health Service gender diversity service received 202 referrals in 2024.
(b) 178 children and young people received care via the service in the 2024 calendar year.
(c) In 2024 28 patients commenced stage 1 puberty blocker treatment after a rigorous assessment and consent process.
(d) 69 patients are currently receiving stage 1 puberty blocker treatment.
(e) 29 patients commenced stage two cross-sex hormone treatment in the 2024 calendar year.
(f) 49 patients are currently receiving stage two cross-sex hormone treatment.
(g) 11 years.
(h) 10 years.
(b) 178 children and young people received care via the service in the 2024 calendar year.
(c) In 2024 28 patients commenced stage 1 puberty blocker treatment after a rigorous assessment and consent process.
(d) 69 patients are currently receiving stage 1 puberty blocker treatment.
(e) 29 patients commenced stage two cross-sex hormone treatment in the 2024 calendar year.
(f) 49 patients are currently receiving stage two cross-sex hormone treatment.
(g) 11 years.
(h) 10 years.
Explore WA Government Data
Search the full archive in the free dashboard, or query programmatically via API.
Explore more
Government Gazette
Appointments, regulatory notices, planning changes.
Hansard
Debates, questions, speeches and sentiment.
Tabled Papers
Reports and documents tabled in Parliament.
Committees
Committee profiles and recent reports.
Regulations
Subsidiary legislation with filters and summaries.
Bills
Proposed laws and parliamentary progress.
Acts
Current WA legislation and summaries.
Explanatory Memoranda
Bills with EMs (text/PDF) available.
Members
MP profiles, party breakdown and rankings.
Pollie Rankings
Data-driven rankings across 19 categories.
Amendment Chains
Track how schemes and regulations evolve over time.